Price Reassessments Will Further Limit Attractiveness Of Pharmaceutical Market In Russia
Pharma & Healthcare / Russia / Wed 11 Sep, 2019
Key View
- Reassessments will reduce prices of commonly used medicines, impacting the revenues of drugmakers operating in the market.
- Pharmaceutical spending growth is already expected to decelerate as a result of the country’s sluggish economic recovery.
- The legislation provides no additional scope for price increases and places a significant